                         SEQUENCE LISTING

<110>  Warenius, Hilmar M
 
<120>  Compositions and uses thereof

<130>  P33044WO/SNB

<150>  GB1602409.3
<151>  2016-02-10

<160>  48    

<170>  PatentIn version 3.5

<210>  1
<211>  6
<212>  PRT
<213>  Homo sapiens

<400>  1

Gly Asp Glu Val Asp Gly 
1               5       


<210>  2
<211>  6
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  cancerocidal group

<400>  2

Pro Arg Gly Pro Arg Pro 
1               5       


<210>  3
<211>  6
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  comparative peptide

<400>  3

Pro Arg Arg Pro Gly Pro 
1               5       


<210>  4
<211>  6
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  comparative peptide

<400>  4

Pro Glu Gly Pro Glu Pro 
1               5       


<210>  5
<211>  6
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Partial sequence of a Jun binding peptide

<400>  5

Pro Arg Lys Pro Arg Pro 
1               5       


<210>  6
<211>  18
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Cyclic peptide


<220>
<221>  MISC_FEATURE
<222>  (1)..(18)
<223>  cyclic peptide

<400>  6

Ala Ala Ala Gly Gly Gly Pro Arg Gly Pro Arg Pro Gly Gly Gly Ala 
1               5                   10                  15      


Ala Ala 
        


<210>  7
<211>  18
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  cyclic peptide


<220>
<221>  MISC_FEATURE
<222>  (1)..(18)
<223>  cyclic peptide

<400>  7

Gly Gly Gly Gly Gly Gly Pro Arg Gly Pro Arg Pro Gly Gly Gly Gly 
1               5                   10                  15      


Gly Gly 
        


<210>  8
<211>  18
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  cyclic peptide


<220>
<221>  MISC_FEATURE
<222>  (1)..(18)
<223>  cyclic peptide

<400>  8

Gly Gly Gly Gly Gly Gly Pro Arg Gly Pro Arg Pro Gly Gly Gly Gly 
1               5                   10                  15      


Gly Gly 
        


<210>  9
<211>  18
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  cyclic peptide


<220>
<221>  MISC_FEATURE
<222>  (1)..(18)
<223>  cyclic peptide

<400>  9

Ala Ala Gly Pro Gly Gly Pro Arg Gly Pro Arg Pro Gly Gly Pro Gly 
1               5                   10                  15      


Ala Ala 
        


<210>  10
<211>  10
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  cassette

<400>  10

Ala Leu Lys Leu Ala Leu Lys Leu Ala Leu 
1               5                   10  


<210>  11
<211>  19
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  cyclic peptide


<220>
<221>  MISC_FEATURE
<222>  (1)..(19)
<223>  cyclic peptide

<400>  11

Pro Arg Gly Pro Arg Pro Val Lys Leu Ala Leu Lys Leu Ala Leu Lys 
1               5                   10                  15      


Leu Ala Leu 
            


<210>  12
<211>  18
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  cyclic peptide


<220>
<221>  MISC_FEATURE
<222>  (1)..(18)
<223>  cyclic peptide

<400>  12

Pro Arg Gly Pro Arg Pro Val Lys Leu Ala Leu Lys Leu Ala Leu Lys 
1               5                   10                  15      


Phe Pro 
        


<210>  13
<211>  17
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  cyclic peptide


<220>
<221>  MISC_FEATURE
<222>  (1)..(17)
<223>  cyclic peptide

<400>  13

Pro Arg Gly Pro Arg Pro Val Ala Leu Lys Leu Ala Leu Lys Leu Ala 
1               5                   10                  15      


Leu 
    


<210>  14
<211>  18
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  cyclic peptide


<220>
<221>  MISC_FEATURE
<222>  (1)..(18)
<223>  cyclic peptide

<400>  14

Pro Arg Gly Pro Arg Pro Val Ala Leu Lys Leu Ala Leu Lys Ala Leu 
1               5                   10                  15      


Ala Leu 
        


<210>  15
<211>  17
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  cyclic peptide


<220>
<221>  MISC_FEATURE
<222>  (1)..(17)
<223>  cyclic peptide

<400>  15

Pro Arg Gly Pro Arg Pro Val Trp Trp Arg Arg Trp Trp Arg Arg Trp 
1               5                   10                  15      


Trp 
    


<210>  16
<211>  17
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  cyclic peptide


<220>
<221>  MISC_FEATURE
<222>  (1)..(17)
<223>  cyclic peptide

<220>
<221>  MOD_RES
<222>  (10)..(10)
<223>  Guanidinophenylalanine

<220>
<221>  MOD_RES
<222>  (11)..(11)
<223>  Guanidinophenylalanine

<220>
<221>  MOD_RES
<222>  (15)..(15)
<223>  guanidinophenylalanine

<220>
<221>  MOD_RES
<222>  (16)..(16)
<223>  guanidinophenylalanine

<400>  16

Pro Arg Gly Pro Arg Pro Val Trp Trp Xaa Xaa Trp Trp Xaa Xaa Trp 
1               5                   10                  15      


Trp 
    


<210>  17
<211>  10
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  cassette

<400>  17

Trp Trp Arg Arg Trp Trp Arg Arg Trp Trp 
1               5                   10  


<210>  18
<211>  10
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  cassette


<220>
<221>  MOD_RES
<222>  (3)..(3)
<223>  guanidinophenylalanine

<220>
<221>  MOD_RES
<222>  (4)..(4)
<223>  guanidinophenylalanine

<220>
<221>  MOD_RES
<222>  (7)..(7)
<223>  guanidinophenylalanine

<220>
<221>  MOD_RES
<222>  (8)..(8)
<223>  guanidinophenylalanine

<400>  18

Trp Trp Xaa Xaa Trp Trp Xaa Xaa Trp Trp 
1               5                   10  


<210>  19
<211>  17
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  cyclic peptide


<220>
<221>  MISC_FEATURE
<222>  (1)..(17)
<223>  cyclic peptide

<400>  19

Pro Glu Gly Pro Glu Pro Val Trp Trp Arg Arg Trp Trp Arg Arg Trp 
1               5                   10                  15      


Trp 
    


<210>  20
<211>  17
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  cyclic peptide


<220>
<221>  MISC_FEATURE
<222>  (1)..(17)
<223>  cyclic peptide

<220>
<221>  MOD_RES
<222>  (2)..(2)
<223>  homocysteic acid

<220>
<221>  MOD_RES
<222>  (5)..(5)
<223>  homocysteic acid

<400>  20

Pro Xaa Gly Pro Xaa Pro Val Trp Trp Arg Arg Trp Trp Arg Arg Trp 
1               5                   10                  15      


Trp 
    


<210>  21
<211>  6
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  cancerocidal group


<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  basic residue, or an acidic residue selected from homocysteic 
       acid azidohomoalanine and glutamic acid

<220>
<221>  MISC_FEATURE
<222>  (3)..(3)
<223>  selected from Gly, Ala, MeGly, and (CH2)3

<220>
<221>  MISC_FEATURE
<222>  (5)..(5)
<223>  If residue 2 is acidic, an acidic residue selected from glutamic 
       acid and homocysteic acid.       If residue 2 is basic, a basic 
       residue.

<400>  21

Pro Xaa Xaa Pro Xaa Pro 
1               5       


<210>  22
<211>  6
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  cancerocidal group


<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  selected from Asp and Glu.

<220>
<221>  MISC_FEATURE
<222>  (5)..(5)
<223>  selected from Asp and Glu.

<400>  22

Pro Xaa Gly Pro Xaa Pro 
1               5       


<210>  23
<211>  6
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  cancerocidal group

<400>  23

Pro Arg Lys Pro Arg Pro 
1               5       


<210>  24
<211>  6
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  cancerocidal group


<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  selected from Asp and Glu

<220>
<221>  MISC_FEATURE
<222>  (5)..(5)
<223>  selected from Asp, N-alkyl Asp, N-aryl Asp, Glu, N-alkyl Glu, 
       N-Aryl Glu.

<220>
<221>  MISC_FEATURE
<222>  (6)..(6)
<223>  selected from Gly, N-alkyl Gly, N-aryl Gly.       If residue 5 is
       Asp, residue 6 is not Gly.

<400>  24

Gly Xaa Glu Val Xaa Xaa 
1               5       


<210>  25
<211>  6
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  cancerocidal group


<220>
<221>  MOD_RES
<222>  (2)..(2)
<223>  Homocysteic acid

<220>
<221>  MOD_RES
<222>  (5)..(5)
<223>  Homocysteic acid

<400>  25

Pro Xaa Gly Pro Xaa Pro 
1               5       


<210>  26
<211>  6
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  cancerocidal group


<220>
<221>  MOD_RES
<222>  (2)..(2)
<223>  homocysteic acid

<220>
<221>  MOD_RES
<222>  (3)..(3)
<223>  MeGly

<220>
<221>  MOD_RES
<222>  (5)..(5)
<223>  homocysteic acid

<400>  26

Pro Xaa Gly Pro Xaa Pro 
1               5       


<210>  27
<211>  6
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  cancerocidal group


<220>
<221>  MOD_RES
<222>  (2)..(2)
<223>  Azidohomoalanine

<220>
<221>  MOD_RES
<222>  (3)..(3)
<223>  MeGly

<220>
<221>  MOD_RES
<222>  (5)..(5)
<223>  Azidohomoalanine

<400>  27

Pro Xaa Gly Pro Xaa Pro 
1               5       


<210>  28
<211>  6
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  cancerocidal group


<220>
<221>  MOD_RES
<222>  (2)..(2)
<223>  Homocysteic acid

<220>
<221>  MOD_RES
<222>  (5)..(5)
<223>  Azidohomoalanine

<400>  28

Pro Xaa Gly Pro Xaa Pro 
1               5       


<210>  29
<211>  7
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  cancerocidal group


<220>
<221>  MOD_RES
<222>  (5)..(5)
<223>  N-methyl aspartic acid

<220>
<221>  MOD_RES
<222>  (6)..(6)
<223>  MeGly

<400>  29

Gly Asp Glu Val Asp Gly Val 
1               5           


<210>  30
<211>  17
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  cyclic peptide


<220>
<221>  MISC_FEATURE
<222>  (1)..(17)
<223>  cyclic peptide

<220>
<221>  MOD_RES
<222>  (2)..(2)
<223>  Homocysteic acid

<220>
<221>  MOD_RES
<222>  (5)..(5)
<223>  homocysteic acid

<220>
<221>  MOD_RES
<222>  (10)..(10)
<223>  guanidinophenylalanine

<220>
<221>  MOD_RES
<222>  (11)..(11)
<223>  guanidinophenylalanine

<220>
<221>  MOD_RES
<222>  (14)..(14)
<223>  guanidinophenylalanine

<220>
<221>  MOD_RES
<222>  (15)..(15)
<223>  guanidinophenylalanine

<400>  30

Pro Xaa Gly Pro Xaa Pro Val Trp Trp Xaa Xaa Trp Trp Xaa Xaa Trp 
1               5                   10                  15      


Trp 
    


<210>  31
<211>  17
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  cyclic peptide


<220>
<221>  MISC_FEATURE
<222>  (1)..(17)
<223>  cyclic peptide

<220>
<221>  MOD_RES
<222>  (2)..(2)
<223>  homocysteic acid

<220>
<221>  MOD_RES
<222>  (5)..(5)
<223>  homocysteic acid

<220>
<221>  MOD_RES
<222>  (8)..(8)
<223>  residue of 3-amino-3-(-2-napthyl)-propionic acid

<220>
<221>  MOD_RES
<222>  (9)..(9)
<223>  residue of 3-amino-3-(-2-napthyl)-propionic acid

<220>
<221>  MOD_RES
<222>  (12)..(12)
<223>  residue of 3-amino-3-(-2-napthyl)-propionic acid

<220>
<221>  MOD_RES
<222>  (13)..(13)
<223>  residue of 3-amino-3-(-2-napthyl)-propionic acid

<220>
<221>  MOD_RES
<222>  (16)..(16)
<223>  residue of 3-amino-3-(-2-napthyl)-propionic acid

<220>
<221>  MOD_RES
<222>  (17)..(17)
<223>  residue of 3-amino-3-(-2-napthyl)-propionic acid

<400>  31

Pro Xaa Gly Pro Xaa Pro Ser Xaa Xaa Arg Arg Xaa Xaa Arg Arg Xaa 
1               5                   10                  15      


Xaa 
    


<210>  32
<211>  17
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  cyclic peptide


<220>
<221>  MISC_FEATURE
<222>  (1)..(17)
<223>  cyclic peptide

<220>
<221>  MOD_RES
<222>  (8)..(8)
<223>  Residue of glutamic 
       acid-gamma-[2-(1-sulfonyl-5-napthyl)-aminoethylamide

<220>
<221>  MOD_RES
<222>  (9)..(9)
<223>  Residue of glutamic 
       acid-gamma-[2-(1-sulfonyl-5-napthyl)-aminoethylamide

<220>
<221>  MOD_RES
<222>  (12)..(12)
<223>  Residue of glutamic 
       acid-gamma-[2-(1-sulfonyl-5-napthyl)-aminoethylamide

<220>
<221>  MOD_RES
<222>  (13)..(13)
<223>  Residue of glutamic 
       acid-gamma-[2-(1-sulfonyl-5-napthyl)-aminoethylamide

<220>
<221>  MOD_RES
<222>  (16)..(16)
<223>  Residue of glutamic 
       acid-gamma-[2-(1-sulfonyl-5-napthyl)-aminoethylamide

<220>
<221>  MOD_RES
<222>  (17)..(17)
<223>  Residue of glutamic 
       acid-gamma-[2-(1-sulfonyl-5-napthyl)-aminoethylamide

<400>  32

Pro Arg Gly Pro Arg Pro Val Xaa Xaa Arg Arg Xaa Xaa Arg Arg Xaa 
1               5                   10                  15      


Xaa 
    


<210>  33
<211>  17
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  cyclic peptide


<220>
<221>  MISC_FEATURE
<222>  (1)..(17)
<223>  cyclic peptide

<220>
<221>  MOD_RES
<222>  (2)..(2)
<223>  homocysteic acid

<220>
<221>  MOD_RES
<222>  (5)..(5)
<223>  Azidohomoalanine

<400>  33

Pro Xaa Gly Pro Xaa Pro Val Trp Trp Arg Arg Trp Trp Arg Arg Trp 
1               5                   10                  15      


Trp 
    


<210>  34
<211>  17
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  cyclic peptide


<220>
<221>  MISC_FEATURE
<222>  (1)..(17)
<223>  cyclic peptide

<220>
<221>  MOD_RES
<222>  (2)..(2)
<223>  homocysteic acid

<220>
<221>  MOD_RES
<222>  (5)..(5)
<223>  homocysteic acid

<220>
<221>  MOD_RES
<222>  (8)..(8)
<223>  residue of 3-amino-3-(-2-napthyl)-propionic acid

<220>
<221>  MOD_RES
<222>  (9)..(9)
<223>  residue of 3-amino-3-(-2-napthyl)-propionic acid

<220>
<221>  MOD_RES
<222>  (10)..(10)
<223>  homocysteic acid

<220>
<221>  MOD_RES
<222>  (11)..(11)
<223>  homocysteic acid

<220>
<221>  MOD_RES
<222>  (12)..(12)
<223>  residue of 3-amino-3-(-2-napthyl)-propionic acid

<220>
<221>  MOD_RES
<222>  (13)..(13)
<223>  residue of 3-amino-3-(-2-napthyl)-propionic acid

<220>
<221>  MOD_RES
<222>  (14)..(14)
<223>  homocysteic acid

<220>
<221>  MOD_RES
<222>  (15)..(15)
<223>  homocysteic acid

<220>
<221>  MOD_RES
<222>  (16)..(16)
<223>  residue of 3-amino-3-(-2-napthyl)-propionic acid

<220>
<221>  MOD_RES
<222>  (17)..(17)
<223>  residue of 3-amino-3-(-2-napthyl)-propionic acid

<400>  34

Pro Xaa Gly Pro Xaa Pro Val Xaa Xaa Xaa Xaa Xaa Xaa Xaa Xaa Xaa 
1               5                   10                  15      


Xaa 
    


<210>  35
<211>  17
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  cyclic peptide


<220>
<221>  MISC_FEATURE
<222>  (1)..(17)
<223>  cyclic peptide

<220>
<221>  MOD_RES
<222>  (2)..(2)
<223>  homocysteic acid

<220>
<221>  MOD_RES
<222>  (5)..(5)
<223>  azidohomoalanine

<220>
<221>  MOD_RES
<222>  (8)..(8)
<223>  residue of 3-amino-3-(-2-napthyl)-propionic acid

<220>
<221>  MOD_RES
<222>  (9)..(9)
<223>  residue of 3-amino-3-(-2-napthyl)-propionic acid

<220>
<221>  MOD_RES
<222>  (10)..(10)
<223>  homocysteic acid

<220>
<221>  MOD_RES
<222>  (11)..(11)
<223>  homocysteic acid

<220>
<221>  MOD_RES
<222>  (12)..(12)
<223>  residue of 3-amino-3-(-2-napthyl)-propionic acid

<220>
<221>  MOD_RES
<222>  (13)..(13)
<223>  residue of 3-amino-3-(-2-napthyl)-propionic acid

<220>
<221>  MOD_RES
<222>  (14)..(14)
<223>  homocysteic acid

<220>
<221>  MOD_RES
<222>  (15)..(15)
<223>  homocysteic acid

<220>
<221>  MOD_RES
<222>  (16)..(16)
<223>  residue of 3-amino-3-(-2-napthyl)-propionic acid

<220>
<221>  MOD_RES
<222>  (17)..(17)
<223>  residue of 3-amino-3-(-2-napthyl)-propionic acid

<400>  35

Pro Xaa Gly Pro Xaa Pro Val Xaa Xaa Xaa Xaa Xaa Xaa Xaa Xaa Xaa 
1               5                   10                  15      


Xaa 
    


<210>  36
<211>  17
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  cyclic peptide


<220>
<221>  MISC_FEATURE
<222>  (1)..(17)
<223>  cyclic peptide

<220>
<221>  MOD_RES
<222>  (2)..(2)
<223>  azidohomoalanine

<220>
<221>  MOD_RES
<222>  (3)..(3)
<223>  MeGly

<220>
<221>  MOD_RES
<222>  (5)..(5)
<223>  azidohomoalanine

<220>
<221>  MOD_RES
<222>  (8)..(8)
<223>  residue of 3-amino-3-(-2-napthyl)-propionic acid

<220>
<221>  MOD_RES
<222>  (9)..(9)
<223>  residue of 3-amino-3-(-2-napthyl)-propionic acid

<220>
<221>  MOD_RES
<222>  (10)..(10)
<223>  homocysteic acid

<220>
<221>  MOD_RES
<222>  (11)..(11)
<223>  homocysteic acid

<220>
<221>  MOD_RES
<222>  (12)..(12)
<223>  residue of 3-amino-3-(-2-napthyl)-propionic acid

<220>
<221>  MOD_RES
<222>  (13)..(13)
<223>  residue of 3-amino-3-(-2-napthyl)-propionic acid

<220>
<221>  MOD_RES
<222>  (14)..(14)
<223>  homocysteic acid

<220>
<221>  MOD_RES
<222>  (15)..(15)
<223>  homocysteic acid

<220>
<221>  MOD_RES
<222>  (16)..(16)
<223>  residue of 3-amino-3-(-2-napthyl)-propionic acid

<220>
<221>  MOD_RES
<222>  (17)..(17)
<223>  residue of 3-amino-3-(-2-napthyl)-propionic acid

<220>
<221>  MOD_RES
<222>  (17)..(17)
<223>  residue of 3-amino-3-(-2-napthyl)-propionic acid

<400>  36

Pro Xaa Gly Pro Xaa Pro Val Xaa Xaa Xaa Xaa Xaa Xaa Xaa Xaa Xaa 
1               5                   10                  15      


Xaa 
    


<210>  37
<211>  6
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  cancerocidal group


<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Any natural or unnatural amino acid bearing an acidic side chain.

<220>
<221>  MISC_FEATURE
<222>  (3)..(3)
<223>  Selected from Gly, Ala, MeGly and (CH2)3

<220>
<221>  MISC_FEATURE
<222>  (5)..(5)
<223>  Any natural or unnatural amino acid bearing an acidic side-chain.

<400>  37

Pro Xaa Xaa Pro Xaa Pro 
1               5       


<210>  38
<211>  16
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  cassette

<400>  38

Arg Arg Trp Arg Arg Trp Trp Arg Arg Trp Trp Arg Arg Trp Arg Arg 
1               5                   10                  15      


<210>  39
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  cassette


<220>
<221>  MISC_FEATURE
<222>  (1)..(8)
<223>  cyclic peptide

<400>  39

Trp Arg Trp Arg Trp Arg Trp Arg 
1               5               


<210>  40
<211>  17
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  cyclic peptide


<220>
<221>  MISC_FEATURE
<222>  (1)..(17)
<223>  cyclic peptide

<220>
<221>  MOD_RES
<222>  (5)..(5)
<223>  N-methyl aspartic acid

<220>
<221>  MOD_RES
<222>  (6)..(6)
<223>  MeGly

<400>  40

Gly Asp Gly Val Asp Gly Val Trp Trp Arg Arg Trp Trp Arg Arg Trp 
1               5                   10                  15      


Trp 
    


<210>  41
<211>  6
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  cancerocidal group


<220>
<221>  MOD_RES
<222>  (2)..(2)
<223>  Azidohomoalanine

<220>
<221>  MOD_RES
<222>  (5)..(5)
<223>  Homocysteic acid

<400>  41

Pro Ala Gly Pro Glu Pro 
1               5       


<210>  42
<211>  6
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  cancerocidal group


<220>
<221>  MOD_RES
<222>  (2)..(2)
<223>  Azidohomoalanine

<220>
<221>  MOD_RES
<222>  (5)..(5)
<223>  Azidohomoalanine

<400>  42

Pro Ala Gly Pro Ala Pro 
1               5       


<210>  43
<211>  17
<212>  PRT
<213>  Artificial sequence

<220>
<223>  cyclic peptide


<220>
<221>  MISC_FEATURE
<222>  (1)..(17)
<223>  cyclic peptide

<220>
<221>  MOD_RES
<222>  (2)..(2)
<223>  Homocysteic acid

<220>
<221>  MOD_RES
<222>  (5)..(5)
<223>  Homocysteic acid

<220>
<221>  MOD_RES
<222>  (10)..(10)
<223>  residue of 3-amino-3-(-2-napthyl)-propionic acid

<220>
<221>  MOD_RES
<222>  (11)..(11)
<223>  residue of 3-amino-3-(-2-napthyl)-propionic acid

<220>
<221>  MOD_RES
<222>  (14)..(14)
<223>  residue of 3-amino-3-(-2-napthyl)-propionic acid

<220>
<221>  MOD_RES
<222>  (15)..(15)
<223>  residue of 3-amino-3-(-2-napthyl)-propionic acid

<400>  43

Pro Xaa Gly Pro Xaa Pro Val Arg Arg Xaa Xaa Arg Arg Xaa Xaa Arg 
1               5                   10                  15      


Arg 
    


<210>  44
<211>  17
<212>  PRT
<213>  Artificial sequence

<220>
<223>  cyclic peptide


<220>
<221>  MISC_FEATURE
<222>  (1)..(17)
<223>  cyclic peptide

<220>
<221>  MOD_RES
<222>  (2)..(2)
<223>  Azidohomoalanine

<220>
<221>  MOD_RES
<222>  (5)..(5)
<223>  Azidohomoalanine

<220>
<221>  MOD_RES
<222>  (10)..(10)
<223>  residue of 3-amino-3-(-2-napthyl)-propionic acid

<220>
<221>  MOD_RES
<222>  (11)..(11)
<223>  residue of 3-amino-3-(-2-napthyl)-propionic acid

<220>
<221>  MOD_RES
<222>  (14)..(14)
<223>  residue of 3-amino-3-(-2-napthyl)-propionic acid

<220>
<221>  MOD_RES
<222>  (15)..(15)
<223>  residue of 3-amino-3-(-2-napthyl)-propionic acid

<400>  44

Pro Xaa Gly Pro Xaa Pro Ser Arg Arg Xaa Xaa Arg Arg Xaa Xaa Arg 
1               5                   10                  15      


Arg 
    


<210>  45
<211>  17
<212>  PRT
<213>  Artificial sequence

<220>
<223>  cyclic peptide


<220>
<221>  MISC_FEATURE
<222>  (1)..(17)
<223>  cyclic peptide

<220>
<221>  MOD_RES
<222>  (2)..(2)
<223>  Azidohomoalanine

<220>
<221>  MOD_RES
<222>  (5)..(5)
<223>  Azidohomoalanine

<220>
<221>  MOD_RES
<222>  (8)..(8)
<223>  guanidinophenylalanine

<220>
<221>  MOD_RES
<222>  (9)..(9)
<223>  guanidinophenylalanine

<220>
<221>  MOD_RES
<222>  (10)..(10)
<223>  residue of 3-amino-3-(-2-napthyl)-propionic acid

<220>
<221>  MOD_RES
<222>  (11)..(11)
<223>  residue of 3-amino-3-(-2-napthyl)-propionic acid

<220>
<221>  MOD_RES
<222>  (12)..(12)
<223>  guanidinophenylalanine

<220>
<221>  MOD_RES
<222>  (13)..(13)
<223>  guanidinophenylalanine

<220>
<221>  MOD_RES
<222>  (14)..(14)
<223>  residue of 3-amino-3-(-2-napthyl)-propionic acid

<220>
<221>  MOD_RES
<222>  (15)..(15)
<223>  residue of 3-amino-3-(-2-napthyl)-propionic acid

<220>
<221>  MOD_RES
<222>  (16)..(16)
<223>  guanidinophenylalanine

<220>
<221>  MOD_RES
<222>  (17)..(17)
<223>  guanidinophenylalanine

<400>  45

Pro Xaa Gly Pro Xaa Pro Ser Xaa Xaa Xaa Xaa Xaa Xaa Xaa Xaa Xaa 
1               5                   10                  15      


Xaa 
    


<210>  46
<211>  17
<212>  PRT
<213>  Artificial sequence

<220>
<223>  cyclic peptide


<220>
<221>  MISC_FEATURE
<222>  (1)..(17)
<223>  cyclic peptide

<220>
<221>  MOD_RES
<222>  (2)..(2)
<223>  Homocysteic acid

<220>
<221>  MOD_RES
<222>  (5)..(5)
<223>  Homocysteic acid

<220>
<221>  MOD_RES
<222>  (8)..(8)
<223>  Residue of glutamic 
       acid-gamma-[2-(1-sulfonyl-5-napthyl)-aminoethylamide

<220>
<221>  MOD_RES
<222>  (9)..(9)
<223>  Residue of glutamic 
       acid-gamma-[2-(1-sulfonyl-5-napthyl)-aminoethylamide

<220>
<221>  MOD_RES
<222>  (10)..(10)
<223>  residue of 3-amino-3-(-2-napthyl)-propionic acid

<220>
<221>  MOD_RES
<222>  (11)..(11)
<223>  residue of 3-amino-3-(-2-napthyl)-propionic acid

<220>
<221>  MOD_RES
<222>  (12)..(12)
<223>  Residue of glutamic 
       acid-gamma-[2-(1-sulfonyl-5-napthyl)-aminoethylamide

<220>
<221>  MOD_RES
<222>  (13)..(13)
<223>  Residue of glutamic 
       acid-gamma-[2-(1-sulfonyl-5-napthyl)-aminoethylamide

<220>
<221>  MOD_RES
<222>  (14)..(14)
<223>  residue of 3-amino-3-(-2-napthyl)-propionic acid

<220>
<221>  MOD_RES
<222>  (15)..(15)
<223>  residue of 3-amino-3-(-2-napthyl)-propionic acid

<220>
<221>  MOD_RES
<222>  (16)..(16)
<223>  Residue of glutamic 
       acid-gamma-[2-(1-sulfonyl-5-napthyl)-aminoethylamide

<220>
<221>  MOD_RES
<222>  (17)..(17)
<223>  Residue of glutamic 
       acid-gamma-[2-(1-sulfonyl-5-napthyl)-aminoethylamide

<400>  46

Pro Xaa Gly Pro Xaa Pro Ser Xaa Xaa Xaa Xaa Xaa Xaa Xaa Xaa Xaa 
1               5                   10                  15      


Xaa 
    


<210>  47
<211>  17
<212>  PRT
<213>  Artificial sequence

<220>
<223>  cyclic peptide


<220>
<221>  MISC_FEATURE
<222>  (1)..(17)
<223>  cyclic peptide

<220>
<221>  MOD_RES
<222>  (2)..(2)
<223>  Azidohomoalanine

<220>
<221>  MOD_RES
<222>  (5)..(5)
<223>  Azidohomoalanine

<220>
<221>  MOD_RES
<222>  (8)..(8)
<223>  Residue of glutamic 
       acid-gamma-[2-(1-sulfonyl-5-napthyl)-aminoethylamide

<220>
<221>  MOD_RES
<222>  (9)..(9)
<223>  Residue of glutamic 
       acid-gamma-[2-(1-sulfonyl-5-napthyl)-aminoethylamide

<220>
<221>  MOD_RES
<222>  (10)..(10)
<223>  residue of 3-amino-3-(-2-napthyl)-propionic acid

<220>
<221>  MOD_RES
<222>  (11)..(11)
<223>  residue of 3-amino-3-(-2-napthyl)-propionic acid

<220>
<221>  MOD_RES
<222>  (12)..(12)
<223>  Residue of glutamic 
       acid-gamma-[2-(1-sulfonyl-5-napthyl)-aminoethylamide

<220>
<221>  MOD_RES
<222>  (13)..(13)
<223>  Residue of glutamic 
       acid-gamma-[2-(1-sulfonyl-5-napthyl)-aminoethylamide

<220>
<221>  MOD_RES
<222>  (14)..(14)
<223>  residue of 3-amino-3-(-2-napthyl)-propionic acid

<220>
<221>  MOD_RES
<222>  (15)..(15)
<223>  residue of 3-amino-3-(-2-napthyl)-propionic acid

<220>
<221>  MOD_RES
<222>  (16)..(16)
<223>  Residue of glutamic 
       acid-gamma-[2-(1-sulfonyl-5-napthyl)-aminoethylamide

<220>
<221>  MOD_RES
<222>  (17)..(17)
<223>  Residue of glutamic 
       acid-gamma-[2-(1-sulfonyl-5-napthyl)-aminoethylamide

<400>  47

Pro Xaa Gly Pro Xaa Pro Ser Xaa Xaa Xaa Xaa Xaa Xaa Xaa Xaa Xaa 
1               5                   10                  15      


Xaa 
    


<210>  48
<211>  17
<212>  PRT
<213>  Artificial sequence

<220>
<223>  cyclic peptide


<220>
<221>  MISC_FEATURE
<222>  (1)..(17)
<223>  cyclic peptide

<220>
<221>  MOD_RES
<222>  (8)..(8)
<223>  Residue of glutamic 
       acid-gamma-[2-(1-sulfonyl-5-napthyl)-aminoethylamide

<220>
<221>  MOD_RES
<222>  (9)..(9)
<223>  Residue of glutamic 
       acid-gamma-[2-(1-sulfonyl-5-napthyl)-aminoethylamide

<220>
<221>  MOD_RES
<222>  (10)..(10)
<223>  residue of 3-amino-3-(-2-napthyl)-propionic acid

<220>
<221>  MOD_RES
<222>  (11)..(11)
<223>  residue of 3-amino-3-(-2-napthyl)-propionic acid

<220>
<221>  MOD_RES
<222>  (12)..(12)
<223>  Residue of glutamic 
       acid-gamma-[2-(1-sulfonyl-5-napthyl)-aminoethylamide

<220>
<221>  MOD_RES
<222>  (13)..(13)
<223>  Residue of glutamic 
       acid-gamma-[2-(1-sulfonyl-5-napthyl)-aminoethylamide

<220>
<221>  MOD_RES
<222>  (14)..(14)
<223>  residue of 3-amino-3-(-2-napthyl)-propionic acid

<220>
<221>  MOD_RES
<222>  (15)..(15)
<223>  residue of 3-amino-3-(-2-napthyl)-propionic acid

<220>
<221>  MOD_RES
<222>  (16)..(16)
<223>  Residue of glutamic 
       acid-gamma-[2-(1-sulfonyl-5-napthyl)-aminoethylamide

<220>
<221>  MOD_RES
<222>  (17)..(17)
<223>  Residue of glutamic 
       acid-gamma-[2-(1-sulfonyl-5-napthyl)-aminoethylamide

<400>  48

Pro Arg Gly Pro Arg Pro Ser Xaa Xaa Xaa Xaa Xaa Xaa Xaa Xaa Xaa 
1               5                   10                  15      


Xaa 
    


